Related references
Note: Only part of the references are listed.Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients
Chyi-Huey Bai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Association Between Heme Oxygenase-1 Gene Promoter Polymorphisms and Type 2 Diabetes in a Chinese Population
Fangfang Song et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease
Jeffrey W. Stephens et al.
ATHEROSCLEROSIS (2009)
Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia
Marta M. M. F. Duarte et al.
CLINICAL BIOCHEMISTRY (2009)
Associations Between Single Nucleotide Polymorphisms on Chromosome 9p21 and Risk of Coronary Heart Disease in Chinese Han Population
Li Zhou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients
Ying-Hwa Chen et al.
DIABETES CARE (2008)
Hemoxygenase-1 in cardiovascular disease
Naglaa K. Idriss et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
HO-1 promoter polymorphism associated with rheumatoid arthritis
Blanca Rueda et al.
ARTHRITIS AND RHEUMATISM (2007)
Using lymphocyte and plasma Hsp70 as biomarkers for assessing coke oven exposure among steel workers
Xiaobo Yang et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2007)
Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients
Jelena Kotur-Stevuljevic et al.
CLINICAL BIOCHEMISTRY (2007)
Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation
Angelo A. Chora et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults
Yangfeng Wu et al.
CIRCULATION (2006)
Heme oxygenase-1 - A novel drug target for atherosclerotic diseases?
Roland Stocker et al.
CIRCULATION (2006)
Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: Role of mitogen-activated protein kinases and Nrf2
AA Anwar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Heme oxygenase and atherosclerosis
T Morita
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
The role of heme oxygenase-1 promoter polymorphisms in human disease
M Exner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function
YH Chen et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors
H Kaneda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients
YH Chen et al.
HUMAN GENETICS (2002)
Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits
K Ishikawa et al.
CIRCULATION (2001)
Heme oxygenase-1 protects against vascular constriction and proliferation
HJ Duckers et al.
NATURE MEDICINE (2001)
Total serum bilirubin and risk of cardiovascular disease in the Framingham Offspring Study
L Djoussé et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice
K Ishikawa et al.
CIRCULATION RESEARCH (2001)
Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema
N Yamada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
